The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT05464095
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 100 participants
- Registry
-
NCT05464095
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT05464095. Randomized; double masking; primary purpose treatment. Start 2023-01-01 (actual); primary completion 2027-05-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study
- Acronym
- MOVE PAH)
- Condition
- Pulmonary Arterial Hypertension
- Intervention (Device)
- mHealth Intervention
- Intervention (Device)
- Usual Care
- Lead sponsor
- Vanderbilt University Medical Center
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct05464095- Content hash
9f5c7852b7824717dd5fae78580e3df3b1002732fdb5d97ccd646ba7f475fd7d